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ABSTRACT
Ganglioside patterns of a cloned Simian virus 40- (SV40) induced hamster tumor cell
(CI2TSV5-S), its normal variant (CI 2TSV5-R) which are C12TSV5-S gradually adapted
to grow in the presence of 2 µg/ml actinomycin D and exhibit certain normal phenotypic
characteristics, and its back variant (C12TSV5-RR), which are C12TSV5-R cells grown in
the absence of actinomycin D for more than 60 passages and which exhibit greater pheno-
typic similarity to CI2TSV5-S cells, have been analyzed. All three cell lines contain N(ace-
tylneuraminyl) galactosylglycosyl ceramide (hematoside, GM3), N-acetylgalactosaminyl
(N-acetylneuraminyl) galactosylglucosyl ceramide (GM2), and a higher ganglioside tenta-
tively identified as disialohematoside . However, C12TSV5-R have more GM2 than C12TSV5-S
whereas C12TSV5-RR contain an intermediate amount of GM2 . The amount of GM2
is correlative with the activity of UDP-N-acetylgalactosamine : hematoside N-acetyl-
galactosaminyl transferase in the extract of the three cell lines and with their agglutination
by wheat germ agglutinin .
Alterations in the pattern of gangliosides of cul-
tured cells after transformation by oncogenic DNA
viruses has been shown by a number of investi-
gators (1-5). This is also true for chemically in-
duced hepatomas which exhibit a simplified pat-
tern of gangliosides compared to normal liver
(6-8). In other studies, it has been reported that
the ganglioside pattern changes when cultured
normal cells become confluent (9, 10). These
studies led Hakomori et al . (10) to propose that
addition of glycosyl groups such as a-galactosyl,
a-N-acetylgalactosaminyl, and neuraminyl to
precursor glycolipids and gangliosides of growing
cells renders the cells contact sensitive. Addition of
these groups is considered to be due to an aug-
mentation in the activities of nucleoside diphos-
phate sugars : glycolipid glycosyl transferases on
cell-to-cell contact . Malignant cells are presumed
to lack this response and hence exhibit loss of con-
tact inhibition of growth and movement .
Using mouse cell lines, Cumar et al. (11) showed
that simian virus 40 (SV40) and polyoma-trans-
formed cells had a reduced content of higher
ganglioside homologues and a lower activity of
N-acetylgalactosaminyl transferase (UDP-N-ace-
tylgalactosaminyl :hematoside N-acetylgalactos-
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307aminyl transferase) when compared to counterpart
normal cells. More recently Mora et al . (12) have
demonstrated that flat revertants of virally trans-
formed cells that exhibit normal phenotypic
growth properties in culture show a trend of re-
version in ganglioside pattern and in the activity
of the above enzyme. However, the ganglioside
patterns of flat polyoma and SV40 revertants
differ from one another and are not identical to
that of normal mouse cells, thus leaving open the
possibility of clonal selection during the isolation
of flat revertants . Yogeeswaran et al. (13) have
shown that different clones of virally transformed
3T3 cells exhibit different ganglioside patterns . In
order to overcome this objection, it would be
necessary to show that: (a) the variant cell con-
tains the same gangliosides as the original trans-
formed cells from which the variant was derived ;
(b) the alteration in the amount of a ganglioside
in the variant agrees with the augmentation of the
activity of the appropriate enzyme ; and, most im-
portant of all, (c) demonstration of back reversion,
so that the back variant cell shows the phenotypic
behavior, ganglioside concentrations, and enzyme
activity similar to that of the original transformed
cells from which the variant was derived .
In this paper we wish to report results on the
ganglioside patterns, N-acetylgalactosaminyl
transferase activities, and phenotypic properties
of three hamster cell lines which conform to the
above requirements. Our data suggest that there
is a relationship between alteration in the ac-
tivity of an enzyme leading to an altered pattern
of gangliosides and these modifications are ex-
pressed by the phenotypic properties of trans-
formed cells.
MATERIALS AND METHODS
Cell Lines
C L2 Tsv 5-S : This is a cell line which was estab-
lished from a clone of a tumor obtained in a hamster
after subcutaneous injection of SV40 virus. The isola-
tion and properties of this cell line have been de-
scribed by Tournier et al . (14).
C L2 Ts V 5-R : This cell subline was derived from
C12TSV5-S . It is resistant to growth inhibition in the
presence of 2 gg/ml actinomycin D (15). Actino-
mycin D resistance was conferred on the cells by
growing them in gradually increasing concentrations
(0.01-2 µg/ml) through more than 80 passages (15) .
CL2TSV5-RR : These are C12TSV5-R cells which
have been grown through more than 60 passages
in the absence of actinomycin D and are gradually
recovering actinomycin D sensitivity .
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BABY HAMSTER KIDNEY (BHK) CELLS :
These were normal hamster cells which have been
passaged several times and now grow to high cell
densities. They were originally obtained from Dr .
Tournier's laboratory, Villejuif, France.
Cells were grown in a constant temperature
incubator at 37 °C. Eagle's minimum essential
medium (MEM) was supplemented with a four-
fold concentration of amino acids and vitamins
(Grand Island Biological Co ., Grand Island, N. Y.)
and 10% fetal calf serum (Flow Laboratories, Inc .,
Rockville, Md.) . For biochemical studies, cells were
grown in a number of plastic bottles . After the cells
reached confluency, they were scraped with a rubber
policeman and washed with phosphate buffered
saline (PBS) in the cold (0°-5 °C). Approximately
0.3-0.4 ml of packed cells was recovered from 20
bottles. The packed cells were frozen and kept at
-20°C. In some experiments C12TSV5-R cells
were recovered before they reached confluency in
order to compare sialic acid content in growing and
confluent cells.
Growth Characteristics of Cell Cultures
To study the growth and the saturation densities
of the three cell lines used in these experiments, the
cells were detached by trypsin and counted in a
hemacytometer (Burker, Karl Hecht, Bayern, West
Germany) 24 h after seeding and every 24 h
thereafter until they reached confluency.
Viability of Cells
The viability of cells grown in the presence or
absence of actinomycin D was established by two
different methods. One of these was the dye exclusion
test (16), and the other, the plating efficiency of
cells (17). The plating efficiency of the cells was
determined by plating 100, 200, and 500 cells per
Petri dish and 2 wk later the cells were fixed in alcohol
and stained with Unna blue . The number of colonies,
their size, and the number of cells per colony were
counted.
Growth in Agar
To study the colony-forming ability in agar of
the three cell lines used in these experiments, 100,
200, 500, and 1,000 cells of each cell line were grown
in MEM containing 0 .3% of Bacto-agar (Difco
Laboratories, Detroit, Mich .) . The technique is
that described by Montagnier and MacPherson (43).
Agglutination Assay
Cultured cells were removed from bottles after
washing with a 0.2% solution of disodium EDTA in
Ca++- Mg++-free PBS . The suspended cells wereagain washed three times with PBS and diluted
with PBS to give 106 cells/ml. The agglutination
tests were performed in small Petri dishes at 22 °C.
Cell suspensions (0.3 ml) were added to successive
dilutions of 0.3 ml of wheat germ agglutinin (a gift
from Dr. J. Weber, Department of Microbiology,
University of Sherbrooke, Quebec). Agglutination
was measured after 30 min incubation by directly
observing the aggregates under a microscope .
Assay of Tumorigenicity
The cells were trypsinized and washed three times
in PBS. They were resuspended in tissue culture
medium containing no serum . Cell suspensions
containing different numbers of cells were inoculated
subcutaneously into suckling Syrian hamsters. The
development of the tumors was observed by the
the appearance of palpable tumors during a 3 mo
period. The tumor dose 50% (TD50) was calculated
according to Reed and Muench (18).
Isolation of Gangliosides
Gangliosides were isolated according to Yogees-
waran et al. (19). The extraction procedure of
Suzuki (20) was employed .
Separation, Identification, and Quantitative
Estimation of Gangliosides
Aliquots of ganglioside fractions containing ap-
proximately 10-20 jig sialic acid (determined ac-
cording to Miettinen and Takki-Luukkainen [21])
and obtained from an equal amount of tissue (on
the basis of milligrams of protein) were spotted on
thin-layer plates (silica gel G, Merck, Sharp &Dohme,
Montreal) and the plates developed in chloroform-
methanol-water (60:35 :8, vol/vol/vol). The migra-
tion of various gangliosides was detected by res-
orcinol reagent (22) . Human brain ganglioside
mixture was used as a reference. The identification
of the three major gangliosides in hamster cells was
further confirmed by isolating a ganglioside mixture
from C12TSV5-R cells (2 ml packed cells), separa-
ting them by thin-layer chromatography, cutting
the ends of the plate with a diamond pencil, and
spraying them with resorcinol reagent to locate the
ganglioside bands. Each ganglioside band was re-
moved from the unsprayed part of the plate by
scraping the silica gel and it was eluted by treatment
of the gel powder with CHCl3-McOH-H2O (60 :
30:4.5). Sialic acid in each ganglioside was estimated
according to Aminoff (23) after hydrolysis of the
ganglioside in 0.1 N H2SO4 for I h at 80°C . After
sialic acid determination in an aliquot, the con-
centration of H2SO.1 in the hydrolysate was raised
to 2 N, and the ganglioside was further hydrolyzed
at 100°C for 2 h. Hexosamine was determined after
neutralization with NaHCO3, using the methods
described by Strominger et al . (24) with galactos-
amine as standard. Neutral sugars were determined
by anthrone reagent (25) after treatment of the
hydrolysate with Amberlite MB3 .
Gangliosides were estimated after their separation
on thin-layer plates as described by MacMillan and
Wherret (26) . N-acetylneuraminic acid was used
as a standard (Sigma Chemical Co., St. Louis,
Mo.) .
Assay of UDP-N-Acetylgalactosamine:
Hematoside N-Acetylgalactosaminyl-
Transferase
For the assay of this enzyme, hematoside acceptor
was isolated from dog erythrocytes as described by
Yamakawa et al. (27) and Cumar et al. (11). Dog
erythrocyte ganglioside has been shown to be N-ace-
tylneuraminylgalactosylglucosyl ceramide . The same
hematoside was also isolated as a major ganglioside
from BHK cells. BHK cells contain only traces of
higher ganglioside homologues.
UDP-N-acetylgalactosamine was used as a
glycosyl donor. [ 14C]UDP-N-acetylgalactosamine
(sp act 40 mCi/mmol) was obtained from New
England Nuclear Corp., Boston, Mass. Unlabeled
UDP-N-acetylgalactosamine was a gift from Dr . H.
Schachter, University of Toronto.
Packed frozen cells were defrosted, suspended in 5
vol of distilled water, and homogenized in the cold
in a Potter-Elvehjem homogenizer . Homogeniza-
tion was terminated when all cells were broken
(30-60 s) as monitored by phase-contrast microscopy .
Enough 1 M solution of NaCl was added so that the
final concentration of NaCl in the homogenate was
0.15 M. The homogenate served as a source of the
enzyme.
The procedure employed for the assay of the
enzyme was essentially the same as described by
Cumar et al. (11). The reaction mixture contained :
dog erythrocyte hematoside, 0.1 µmol ; Triton
X-100 (12.5 mg/ml), 40 µl; Tris-HCl buffer (pH,
7.4), 50 µmol ; MnCl2 , 2.5 µmol ; [I- 14C]UDP-N-
acetylgalactosamine (sp act 40 mCi/mmol), 2 .4
nmol ; and homogenate, 50 µl (approximately
100-300 µg protein) . The control contained no
hematoside. The total volume of the reaction mix-
ture was 0.15 ml. The reaction mixture was incu-
bated for 3 h at 37°C. It was inactivated by the
addition of 2.4 ml of CHCl2-MeOH (2 :1) and the
mixture left at 5 °C overnight. The suspension was
filtered through Whatman no. 50 filter paper and
the retained protein washed twice with 2 ml of
CHC13-McOH-water (60:30 :4.5). The filtrate was
passed through a column (0.1 X 7 cm) packed with
superfine Sephadex G-25 (Pharmacia Fine Chem-
icals Inc., Uppsala, Sweden) and equilibrated with
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309CHC13-McOH-H2O (60:30 :4.5). After all the
filtrate had passed, the column was washed with
4 ml of the same solvent. The eluate was evaporated
to dryness and the radioactivity was determined by
liquid scintillation spectrometry.
To visualize the formation of N-acetylgalactos-
atninyl(N-acetylneuraminyl) galactosylglycosyl cera-
mide from N-acetylhematoside and UDP-N-acetyl-
galactosamine on thin-layer plate, the above reac-
tion mixture was modified to contain 0.1 µmol
hematoside from BHK cells (instead of dog erytho-
cyte hematoside) and 0.1 µmol unlabeled UDP-N-
acetylgalactosamine (instead of labeled UDP-N-
acetylgalactosamine) . The reaction mixture was
incubated for 3 h at 37 °C, inactivated by 2.4 ml of
CHC1 3-MeOH (2 :1), and filtered after overnight
keeping in the cold. The precipitate was washed
with 2 ml of CHC13-McOH-H2O (60:30 :4.5).
The filtrate was dried and chromatographed on a
thin-layer plate. The gangliosides were detected by
spraying resorcinol spray reagent.
RESULTS
Characteristics of the Cell Lines
Simard and Cassingena (15) have described
growth characteristics of C12TSV5-S and
C12TSV5-R cells. The actinomycin D-resistant
cells grow much more slowly than actinomycin
D-sensitive cells. We have confirmed this finding.
Resistant cells grown in the absence of actino-
TABLE I
Biological Characteristics of the Three Cell Lines
mycin D have a higher growth rate than the cells
grown in the presence of the antibiotic (not
shown) . The saturation densities of C12TSV 5-S,
C12TSV5-R, and C12TSV5-RR are shown in
Table I.
Both the actinomycin D-sensitive and -resistant
cells produced tumors when injected into ham-
sters (Table I). However, the number of cells
required for tumor production by actinomycin
D-resistant cells is 25 times greater than is re-
quired for the production of tumors by actino-
mycin D-sensitive cells. It should be noted that
actinomycin D is not administered to the animals
after the injection of actinomycin D-resistant cells,
thus leaving open the possibility for back rever-
sion. The tumors produced could be sensitive to
toxicity of actinomycin D, but this has not been
tested.
The agglutination behavior of these cell lines
with wheat germ agglutin shows that actinomycin
D-sensitive cells are agglutinated by a much lower
concentration of the agglutinin than is required
for the agglutination of actinomycin D-resistant
cells (Table I). Resistant cells which have been
grown for 60 passages in the absence of actino-
mycin D require an intermediate concentration of
agglutinin for their agglutination . Agglutination
of these cells is reversed by N-acetylhexosamine .
Further, it is to be noted that C12TSV5-R cells
* Calculated at the end of the exponential growth phase after seeding 7 X 10 5 cells per Petri dish. The
results are an average for 10 Petri dishes .
$ TD50 calculated 3 mo after inoculation of cells into suckling hamsters (eight animals per dilution) .
§ 100% agglutination means that all the cells are clumped after 30 min in contact with wheat germ agglu-
tinin and clumps are formed by at least 25 cells .
11 100, 200, and 500 cells of each cell line were seeded per Petri dish . Colonies were counted 2 wk after
seeding. The results are an average for ten Petri dishes .
¶ The technique employed was that described by Montagnier and MacPherson (43). 100 and 500 cells
of each cell line were seeded . Colonies were counted 3 wk after seeding. The results are an average for
ten Petri dishes .
ND, not determined .
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Cell line
Saturation
density (cell/
cm2 X 10- 5) *
Tumori-
genicityt
Concentration of
wheat germ
agglutinin for 100%
agglutination
(µg/ml)§
Plating efficiency(
Colony
efficiency in
agar
In the
absence of
actinomycin D
In the presence
of actinomycin
D (2 µg/ml)
% % %
C12TSV5-S 1 .17 105 50 54 0 12 .7
C12TSV5-R 0 .47 2 .5 X 106 370 30 31 0
CI2TSV5-RR 1 .18 ND 100 48 4 13.1grown in the absence of actinomycin D for 60
passages resulting in the development of C12TSV 5-
RR cells have gained partially their sensitivity to
actinomycin D as well as their ability to grow in
agar (Table I). The resistant cells (C12TSV5-R)
neither grow in agar in the presence or absence
of actinomycin D nor do they allow actinomycin
D entry into the cell resulting in their death.
In these respects the behavior of C12TSV5-RR is
intermediate between the behavior of C12TSV5-R
and C12TSV5-S cells.
The plating efficiency of C12TSV5-R is the
same in the presence or absence of actinomycin D,
whereas that of C12TSV5-S is 0 in the presence of
actinomycin D and 54% in the absence of ac-
tinomycin D. The back variant (C12TSV5-RR)
cells exhibit 48% plating efficiency in the absence
and 4% in the presence of actinomycin D . The
fact that plating efficiency of C12TSV5-R cells is
the same in the presence or absence of actinomy-
cin D is indicative that slow growth rate of these
cells is not due to the derivation of actinomycin
D-sensitive cells from actinomycin D-resistant
cells. Furthermore, it is apparent that C1 2TSV5-
RR has not completely reverted to the character
of actinomycin D-sensitive cells, since it still has
4% of the cells which are viable in the presence
of actinomycin D.
Morphologically, the three kinds of cells are
similar to one another. However, when the cells
occur in groups they are spindle shaped whereas
single cells are round in shape . Since actinomycin
D-resistant cells are sparsely populated on the
culture dish, apparently there are more round-
shaped cells and a few groups of spindle shaped
in this cell line as compared to actinomycin D-sen-
sitive cells and those grown in the absence of
actinomycin D, which have mostly groups of
large numbers of spindle-shaped cells and a few
round-shaped single cells .
The data described in Table I are consistent
with similar observations made in a paper by
Wicker et al. (28), with the actinomycin D-sensi-
tive and -resistant hamster tumor cells, which
appeared after our work had been submitted for
publication.
Sialic Acid and Galactosamine Contents of
the Cell Lines
It has been observed by a number of investi-
gators that the sialic acid content of cells decreases
after transformation by oncogenic DNA viruses
(29-31) . In Table II are shown the amounts of
sialic acid present in lipid-bound and protein-
bound fractions in the four cell lines used in the
present investigation . The amount of ganglioside-
bound and protein-bound hexosamine is also
given. Since the only ganglioside containing
hexosamine present in these cell lines is GM2,
ganglioside-bound hexosamine can be estimated
from the data presented for GM 2 content in
Table III. It can be seen that the amounts of
sialic acid present in resistant and sensitive cells
is parallel to that reported for normal and DNA
oncogenic virus-transformed cells (32). Resistant
cells grown in the absence of actinomycin D give
an intermediate value between the above two
cell lines, indicating that they are reverting back
to the transformed cell behavior . BHK cells, on the
other hand, contain sialic acid and hexosamine
whose content is similar to that of sensitive cells,
and apparently their phenotypic behavior is
similar to that of spontaneously transformed cells .
TABLE II
Total Sialic Acid and Hexosamine Content of the Cell Lines
The values are an average of two separate experiments except those marked with $
where an average of three experiments is given . Details of the determination pro-
cedure are given under Materials and Methods
* Calculated with valactosamine as standard.
V. N. NIGAM, R. LALLIER, AND C . BRAILOVSKY Biochemical Change in Reversion 311
nmoles sialic acid/mg protein nmoles hexosamine*/mg protein
Type of cells Lipid bound Protein bound Ganglioside bound Protein bound
BHK 4.0 31 .4 <0.5 19 .0
CI2TSV 5-S 3 .88$ 37.2 0 .6 18 .6
C12TSV5-R 5 .82t 60.0 2 .1 29 .0
C12TSV5-RR 4 .5 45 .0 0.8 20 .5TABLE III
Distribution of GM3 and GM2 in Hamster
Cell Lines
The gangliosides were isolated as described in
Materials and Methods. They were separated
by thin-layer chromatography on silica gel G .
The plate was sprayed lightly with resorcinol
spray reagent (19) . It was heated at 150 °C for 5 min
after covering with a glass plate. As soon as color
developed, the plate was removed from the oven,
cooled, and the colored zones of GM3 and GM2
were scraped with a blade . The contents were
transferred to tubes and the sialic acid determina-
tion was carried out with the resorcinol reagent
(19). After the color reaction, the tubes were
centrifuged and the optical density was determined
at 580 and 470 run . This method of estimation has
been described by MacMillan and Wherret (26) .
The values are averages of determination in two
samples of each type of cells.
Ganglioside Pattern of the Cells Lines
In Fig. 1, the ganglioside pattern of the four
cell lines is shown. Three bands appear in the
actinomycin D-resistant, actinomycin D-sensitive,
and -resistant cells grown in the absence of ac-
tinomycin D, whereas BHK cells contain only
one double band of a ganglioside. The neuraminic
acid-hexosamine-hexose ratios of the three ganglio-
sides isolated from actinomycin D-resistant cells
after thin-layer chromatography were as follows:
top band (GM3, neuraminyl-galactosylglycosyl
ceramide), 1 :0 : 1 .8; middle band (GM2, N-acetyl-
galactosaminyl neuraminylgalactosylglycosyl cer-
amide), .0 :0.85 :1 .7; bottom band (DSH, dis-
ialohematoside), 1 :0 :0.78. However, the identi-
fication of bottom band as DSH has to be re-
garded as only tentative since the amount of
this ganglioside isolated was relatively small to
make the identification accurate. These results
are in agreement with those of Hakomori (9)
who also demonstrated the presence of these
three gangliosides in his hamster cell lines .
One of the major differences between actino-
mycin D-resistant and -sensitive cell lines and
actinomycin D-resistant cells grown in the ab-
sence of actinomycin D is that the amounts of
GM2 are different (Table III) although they have
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exactly the same pattern (Fig. 1). On the other
hand, BHK cells demonstrate a different pattern
insofar as they show only GM3 as the major
ganglioside (Fig. 1) . Actinomycin D-resistant
cells contain a higher amount of GM2 than ac-
tinomycin D-sensitive cells; but actinomycin
D-resistant cells grown in the absence of actino-
mycin D show an intermediate amount for GM2
(Table III).
Table IV shows the data on the activity of
N-acetylgalactosamine : hematoside N-acetyl-
galactosaminyl transferase activity in actinomy-
cin D-resistant and -sensitive cells and actinomy-
cin D-resistant cells grown in the absence of ac-
tinomycin D. Actinomycin D-resistant cells
have a much higher activity (threefold) than
actinomycin D-sensitive cells, whereas the actino-
mycin D-resistant cells grown in the absence of
actinomycin D show an intermediate level of
activity between the two cell lines . In Fig. 2, it is
clearly seen that the activity in one of the ho-
mogenates of actinomycin D-resistant cells is
high enough so that the appearance of GM2 can
be observed on thin-layer chromatography of
the gangliosides, whereas in one preparation of
actinomycin D-sensitive cells it is so low that the
GM2 band does not appear in the chromatogram
under identical conditions of incubation and iso-
lation of the gangliosides from the two reaction
mixtures.
DISCUSSION
It is well known that variant cells can be selected
(33, 34) from a population of transformed cells
that have lost transformed properties, but still
contain viral genome. Variants can also be selected
which exhibit certain "normal" and some "trans-
formed" characteristics. For example, variants
have been isolated that are tumorigenic but
have growth properties of normal cells (35, 36),
or those that have a saturation density char-
acteristic of normal cells but a serum requirement
of transformed cells (37) . Although actinomycin
D-resistant cells (C12TSV5-R) were originally
isolated (15) to study the mechanism of the de-
velopment of drug resistance, closer examination
of their phenotypic properties shows that adapta-
tion of the cells to actinomycin D accompanies
cell membrane alteration which gives them many
characteristics of normal cells. These cells grow
slowly, exhibit contact inhibition at confluency,
do not grow in agar, and are agglutinated by a
concentration of wheat germ agglutinin higher
Type of cells GM3 GMz
C12TSV5-R 2 .60 2 .20
C12TSV5-S 1 .94 0 .20
C12TSV5-RR 1 .74 0 .86FIGURE 1 Ganglioside pattern of hamster cell lines . The figure is a photograph of a thin-layer chromato-
gram of ganglioside fractions isolated from the three cell lines . Details of isolation and chromatography
are provided in Materials and Methods . Developing solvent was CHCl3-McOH-NH4OH, 7N-H20
(60:85:1:7, vol/vol/vol/vol) and the chromatogram was run in the ascending direction. The migration
of the gangliosides was detected by spraying with resorcinol reagent (18). Slight upward migration of
the gangliosides on the left-hand side of the photograph is due to slightly higher movement of the solvent
front on that side. In each case the amount of ganglioside applied was equivalent to that obtained from
about 80 mg of cell protein . In other experiments, ganglioside from hamster cells run along side with
human brain ganglioside mixture showed that GM3 and GM2 bands of hamster cells correspond to GMs
and GM2 bands in human brain ganglioside mixture . The bottom hand is tentatively identified as dis-
ialohematoside (see Results) .
than that required for the agglutination of ac-
tinomycin D-sensitive parent cells (C12TSV5-S) .
They also show a higher content of glycolipid and
glycoprotein-bound sialic acid compared to
C12TSV5-S cells, in a manner similar to that re-
ported for normal (3T3) or embryonic cells and
counterpart DNA oncogenic virus-transformed
cells (32). C1 TSV5-R cells can, therefore, be
described as a normal variant of transformed
cells. The only transformed character they ex-
hibit is the presence of viral genome which ex-
presses T antigen; and that these cells develop
tumor when they are injected into recipient ani-
mals at a cell concentration 25 times higher than
is required for tumor development by actinomycin
1)-sensitive cells. However, it has been observed
that tumor development by cultured cells is not
the exclusive property of transformed cells alone
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313TABLE IV
UDP-N-Acetylgalactosamine : Hematoside
N-Acetylgalactosaminyl Transferase
Activity in Hamster Cell Lines
The composition of the reaction mixture and the
measurement of incorporation of [19C]UDP-N-
acetylgalactosamine with hematoside is described
in Materials and Methods.
* These differences are presumably due to the fact
that CI2TSV5-RR cells taken in exp . 2 were at a
62 passage in the absence of actinomycin D, com-
pared to the same cells in passage 30 in exp . 1 .
t Dog erythrocyte hematoside used as acceptor .
The values are corrected for blanks obtained in the
absence of added hematoside.
since cultured normal cells are also tumorigenic
when injected into recipients under appropriate
conditions (3, 38) . On the other hand, it should
be noted that development of resistance to ac-
tinomycin D is not an essential requirement for
a transformed cell to exhibit normal characteris-
tics since normal cells are not resistant to actino-
mycin D; but when transformed cells do become
resistant to actinomycin D, the adaptation results
not only in the reversion of certain properties
towards normal but also in more extensive altera-
tion of the cell membrane so that the cells disallow
the entry of actinomycin D as well as other anti-
biotics (39) . The presence of actinomycin D in the
medium also appears to disallow genetic drift of
C12TSV5-R that is otherwise exhibited as spon-
taneous transformation in most normal embryonic
cells when they are passaged over many genera-
tions. This genetic drift becomes explicit when cells
(CI2TSV5-R) are grown in the absence of actino-
mycin D over many generations, as seen by the
phenotypic behavior of C12TSV5-RR cells.
In this investigation we have observed that at
least one enzyme activity increases in response to
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FIGURE 2 Photograph of a thin-layer chromatogram
of gangliosides isolated from reaction mixtures con-
taining C12TSV5-S (right) and C12TSV5-R (left)
cells incubated for 3 h in the presence of UDP-N-
acetylgalactosamine and BHK hematoside. The
composition of the reaction mixture, the isolation of
gangliosides, and conditions for the development of
the chromatogram are given in Materials and Methods
and in Fig. 1 . The amount of protein in the extracts
was 200 µg in each case.
previous gradual exposure to actinomycin D, and
an alteration in the activity of this enzyme closely
corresponds to alterations in the ganglioside
amounts. Since gangliosides are known to be as-
sociated with cell membranes (5, 40, 41), it is
possible that they may have a functional role in
the transport of actinomycin D . However, it
cannot be ruled out that cell surface glycoproteins
are not involved in actinomycin D entry in the
resistant cells. In fact, increase in protein-bound
sialic acid and galactosamine would suggest that
they could also be a determining factor for actino-
mycin D entry.
Using Pollack's flat revertants of SV40- and
polyoma-transformed 3T3 cells, Mora et al . (12)
have made observations similar to those described
in this paper. However, flat revertants have been
obtained by only two treatments of fluorodeoxy-
uridine, thus leaving open the possibility of clonal
selection. Indeed, the ganglioside pattern of flat
revertants is significantly different from that of
Exp. no. Cell line
Enzyme activity
(N-acetylgalactosamine
incorporated)
cpm/mg protein
1 CI2TSV5-R 40,485
CI2TSV5-S 11,421
CI2TSV5-RR 19,872*
2 C12TSV5-R 56,083
C12TSV 5-S 8,838
C12TSV5-RR 9,249*
3 C12TSV5-R 31,5401
C12TSV 5-S 9, 924$parent 3T3 cells to qualify them as clones which
are phenotypically similar to the normal 3T3
cells, although they carry viral information in the
form of T antigen . The discovery of the flat
revertant in fact demonstrates the ability in
certain cells to suppress viral information necessary
for the expression of the transformed behavior .
In the case of actinomycin D-sensitive cells,
clonal selection is also apparent, since their gangli-
oside pattern is more complex than that of parent
BHK cells. Indeed, actinomycin D-sensitive cells
are a clone derived from a SV40-induced hamster
tumor. Therefore, we can limit our comparisons
only to actinomycin D-sensitive and -resistant
cells and actinomycin D-resistant cells grown in the
absence of actinomycin D in which an identical
pattern of gangliosides exists but only the amounts
of these gangliosides differ. From the estimation of
the GM3 and GM2 and the determination of N-
acetylgalactosamine : hematoside N-acetylgalactos-
aminyl transferase activity, it is clear that the
normal phenotypic behavior of cells is associated
with an increase of bound galactosamine on the
cell surface.
The phenotypically normal state of actinomycin
D-resistant cells seems to be maintained by growth
of these cells in the presence of actinomycin D.
This behavior of actinomycin D resembles that of
dibutyryl cyclic AMP (42) which maintains
normal phenotypic behavior of transformed cells
as long as it is present in the medium, and its
exclusion from the medium causes the cells to
revert back to their transformed state characteris-
tics. This back reversion process is very much
slower in the case of actinomycin D-resistant cells,
indicating that certain secondary changes occur
during the development of actinomycin D re-
sistance which have to be diluted by successive
passages in the absence of actinomycin D before
back reversion can occur .
The present comparative work carried out with
suitable cell lines clearly suggests that functioning
of certain parts of the viral genome (excluding T
antigen) is necessary for the maintenance of
altered growth properties of virally transformed
cells and is subject to modulation (expression or
repression) and it parallels the expression or
repression of a biochemical event, that is, the
activity of an enzyme involved in cell ganglioside
biosynthesis.
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